<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:23 -0700</creation_date>
  <update_date>2013-05-27 11:39:23 -0600</update_date>
  <accession>HMDBP00483</accession>
  <secondary_accessions>
    <accession>5725</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>Bilirubin-specific UDPGT isozyme 1</synonym>
    <synonym>UDP-glucuronosyltransferase 1-A</synonym>
    <synonym>UDP-glucuronosyltransferase 1A1</synonym>
    <synonym>UDPGT 1-1</synonym>
    <synonym>UGT-1A</synonym>
    <synonym>UGT1*1</synonym>
    <synonym>UGT1-01</synonym>
    <synonym>UGT1.1</synonym>
    <synonym>UGT1A</synonym>
    <synonym>hUG-BR1</synonym>
  </synonyms>
  <gene_name>UGT1A1</gene_name>
  <general_function>Involved in transferase activity, transferring hexosyl groups</general_function>
  <specific_function>UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone.
</specific_function>
  <pathways>
    <pathway>
      <name>Pentose and glucuronate interconversions</name>
      <smpdb_id/>
      <kegg_map_id>map00040</kegg_map_id>
    </pathway>
    <pathway>
      <name>Ascorbate and aldarate metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00053</kegg_map_id>
    </pathway>
    <pathway>
      <name>Steroid hormone biosynthesis</name>
      <smpdb_id/>
      <kegg_map_id>map00140</kegg_map_id>
    </pathway>
    <pathway>
      <name>Starch and sucrose metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00500</kegg_map_id>
    </pathway>
    <pathway>
      <name>Retinol metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00830</kegg_map_id>
    </pathway>
    <pathway>
      <name>Porphyrin and chlorophyll metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00860</kegg_map_id>
    </pathway>
    <pathway>
      <name>Metabolism of xenobiotics by cytochrome P450</name>
      <smpdb_id/>
      <kegg_map_id>map00980</kegg_map_id>
    </pathway>
    <pathway>
      <name>Drug metabolism - cytochrome P450</name>
      <smpdb_id/>
      <kegg_map_id>map00982</kegg_map_id>
    </pathway>
    <pathway>
      <name>Drug metabolism - other enzymes</name>
      <smpdb_id/>
      <kegg_map_id>map00983</kegg_map_id>
    </pathway>
    <pathway>
      <name>Chemical carcinogenesis</name>
      <smpdb_id/>
      <kegg_map_id>map05204</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB03325</accession>
      <name>Bilirubin diglucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04482</accession>
      <name>2-Methoxyestrone 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04483</accession>
      <name>Estrone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06224</accession>
      <name>17-beta-Estradiol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10316</accession>
      <name>Acetaminophen glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10317</accession>
      <name>17-beta-Estradiol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10318</accession>
      <name>Pregnanediol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10322</accession>
      <name>17-alpha-Estradiol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10325</accession>
      <name>Ethyl glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10332</accession>
      <name>Bilirubin glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10334</accession>
      <name>Ketoprofen glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10335</accession>
      <name>Estriol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10340</accession>
      <name>Retinyl beta-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10343</accession>
      <name>1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10352</accession>
      <name>3-alpha,20-alpha-Dihydroxy-5-beta-pregnane 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10354</accession>
      <name>16-alpha,17-beta-estriol 17-beta-D-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10356</accession>
      <name>Estriol 3-sulfate 16-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10364</accession>
      <name>11-Hydroxyprogesterone 11-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00054</accession>
      <name>Bilirubin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00010</accession>
      <name>2-Methoxyestrone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00031</accession>
      <name>Androsterone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00145</accession>
      <name>Estrone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00151</accession>
      <name>Estradiol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00153</accession>
      <name>Estriol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00234</accession>
      <name>Testosterone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00295</accession>
      <name>Uridine 5'-diphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00405</accession>
      <name>2-Methoxyestradiol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00490</accession>
      <name>Etiocholanolone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00496</accession>
      <name>3-Methoxy-4-hydroxyphenylglycol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00901</accession>
      <name>Valproic acid glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00935</accession>
      <name>Uridine diphosphate glucuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01013</accession>
      <name>Cotinine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01204</accession>
      <name>trans-3-Hydroxycotinine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01272</accession>
      <name>Nicotine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01852</accession>
      <name>All-trans-retinoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02091</accession>
      <name>Isovalerylglucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02513</accession>
      <name>Lithocholate 3-O-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02577</accession>
      <name>Cholic acid glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02579</accession>
      <name>Glycochenodeoxycholic acid 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02596</accession>
      <name>Deoxycholic acid 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02829</accession>
      <name>Androsterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02833</accession>
      <name>Testosterone sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03141</accession>
      <name>Retinoyl b-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03193</accession>
      <name>Testosterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04484</accession>
      <name>Etiocholanolone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04995</accession>
      <name>Codeine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06203</accession>
      <name>5-alpha-Dihydrotestosterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06765</accession>
      <name>2-Methoxy-estradiol-17b 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06766</accession>
      <name>Estriol-16-Glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10313</accession>
      <name>1-Salicylate glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10315</accession>
      <name>4-Hydroxyandrostenedione glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10319</accession>
      <name>Inodxyl glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10320</accession>
      <name>Cortolone-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10321</accession>
      <name>3,17-Androstanediol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10323</accession>
      <name>Phenethylamine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10324</accession>
      <name>Benzoyl glucuronide (Benzoic acid)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10326</accession>
      <name>Thyroxine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10327</accession>
      <name>Dehydroisoandrosterone 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10328</accession>
      <name>Tyramine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10329</accession>
      <name>Dopamine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10330</accession>
      <name>Cholesterol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10331</accession>
      <name>Palmitoyl glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10333</accession>
      <name>Estriol-17-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10336</accession>
      <name>Epinephrine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10337</accession>
      <name>6-Dehydrotestosterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10338</accession>
      <name>11-Oxo-androsterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10339</accession>
      <name>3-alpha-Androstanediol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10341</accession>
      <name>Dextrorphan O-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10342</accession>
      <name>25-Hydroxyvitamin D2-25-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10344</accession>
      <name>Vitamin D2 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10345</accession>
      <name>Aldosterone 18-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10346</accession>
      <name>Triiodothyronine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10347</accession>
      <name>Octanoylglucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10348</accession>
      <name>Dehydroepiandrosterone 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10350</accession>
      <name>2-Phenylethanol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10351</accession>
      <name>11-beta-Hydroxyandrosterone-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10353</accession>
      <name>15-Hydroxynorandrostene-3,17-dione glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10355</accession>
      <name>Cholestane-3,7,12,25-tetrol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10357</accession>
      <name>Tetrahydroaldosterone-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10359</accession>
      <name>17-Hydroxyandrostane-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10360</accession>
      <name>25-Hydroxyvitamin D2 25-(beta-glucuronide)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10361</accession>
      <name>(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10362</accession>
      <name>6-Hydroxy-5-methoxyindole glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10363</accession>
      <name>5-Hydroxy-6-methoxyindole glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10365</accession>
      <name>3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14440</accession>
      <name>Morphine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13974</accession>
      <name>4'-Hydroxydiclofenac</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13846</accession>
      <name>E-3179</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14826</accession>
      <name>Mycophenolate mofetil</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14842</accession>
      <name>Naltrexone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14850</accession>
      <name>Flurbiprofen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14900</accession>
      <name>Irinotecan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13989</accession>
      <name>O-Desmethylnaproxen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14018</accession>
      <name>4-Hydroxypropofol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15008</accession>
      <name>Suprofen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15108</accession>
      <name>Ezetimibe</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15159</accession>
      <name>Mycophenolic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15179</accession>
      <name>Rifampin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15182</accession>
      <name>Abacavir</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15595</accession>
      <name>Nilotinib</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15608</accession>
      <name>Indacaterol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00127</accession>
      <name>D-Glucuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00580</accession>
      <name>Chondroitin sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00639</accession>
      <name>Galactaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00652</accession>
      <name>Chondroitin 4-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00663</accession>
      <name>Glucaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00693</accession>
      <name>Heparan sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01394</accession>
      <name>Heparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02061</accession>
      <name>Hyaluronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02429</accession>
      <name>(3a,5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02430</accession>
      <name>(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02472</accession>
      <name>(3a,5b,7a,12a)-24-[(carboxymethyl)amino]-1,12-dihydroxy-24-oxocholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02545</accession>
      <name>Galacturonic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02704</accession>
      <name>Iduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03363</accession>
      <name>Pectic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03402</accession>
      <name>Pectin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03976</accession>
      <name>D-Glucuronic acid 1-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10349</accession>
      <name>Estradiol-17alpha 3-D-glucuronoside</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10358</accession>
      <name>17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10366</accession>
      <name>Hyaluronan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11658</accession>
      <name>2,8-Dihydroxyquinoline-beta-D-glucuronide </name>
    </metabolite>
    <metabolite>
      <accession>HMDB11686</accession>
      <name>p-Cresol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12302</accession>
      <name>UDP-D-galacturonate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12304</accession>
      <name>UDP-L-iduronate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13847</accession>
      <name>Losartan N2-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14551</accession>
      <name>Ardeparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14709</accession>
      <name>Fondaparinux sodium</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15356</accession>
      <name>Enoxaparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29212</accession>
      <name>Quercetin 3-O-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29214</accession>
      <name>Quercetin-4'-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29357</accession>
      <name>Betavulgaroside I</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29406</accession>
      <name>Amaranthin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29500</accession>
      <name>Kaempferol 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29844</accession>
      <name>Glyciram</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29881</accession>
      <name>D-Glucaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29917</accession>
      <name>2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29923</accession>
      <name>Xanthan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29938</accession>
      <name>Acaciabiuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29940</accession>
      <name>Alginic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30498</accession>
      <name>Camelliasaponin A1</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30499</accession>
      <name>Camelliasaponin A2</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30976</accession>
      <name>Durupcoside B</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30977</accession>
      <name>Durupcoside A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31022</accession>
      <name>Elatoside I</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31023</accession>
      <name>Achyranthoside D</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31024</accession>
      <name>Achyranthoside C</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31025</accession>
      <name>Betavulgaroside IV</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31026</accession>
      <name>Calenduloside H</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31027</accession>
      <name>Tuberoside B (Ullucus tuberosus)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31353</accession>
      <name>Kudzusaponin SA4</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31656</accession>
      <name>Jaceidin 4'-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31883</accession>
      <name>Sandosaponin B</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31884</accession>
      <name>Sandosaponin A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31959</accession>
      <name>Lablaboside D</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31960</accession>
      <name>Lablaboside E</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31961</accession>
      <name>Lablaboside F</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31965</accession>
      <name>Melilotussaponin O1</name>
    </metabolite>
    <metabolite>
      <accession>HMDB33105</accession>
      <name>N2-Galacturonyl-L-lysine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB33106</accession>
      <name>N6-Galacturonyl-L-lysine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB34379</accession>
      <name>Silenoside A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB34389</accession>
      <name>Silenoside B</name>
    </metabolite>
    <metabolite>
      <accession>HMDB34390</accession>
      <name>Silenoside C</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41796</accession>
      <name>2,2,2-Trichloroethanol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB42049</accession>
      <name>Trichloroethanol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60510</accession>
      <name>SN-38</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60511</accession>
      <name>SN38 glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60464</accession>
      <name>Codeine-6-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41936</accession>
      <name>Morphine-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41937</accession>
      <name>Morphine-6-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41809</accession>
      <name>4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60383</accession>
      <name>4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60498</accession>
      <name>NNAL-N-glucuronide</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>transferase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>transferase activity, transferring glycosyl groups</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>transferase activity, transferring hexosyl groups</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytochrome complex</description>
      <go_id>GO:0070069</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>endoplasmic reticulum membrane</description>
      <go_id>GO:0005789</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>integral to plasma membrane</description>
      <go_id>GO:0005887</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>enzyme binding</description>
      <go_id>GO:0019899</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>enzyme inhibitor activity</description>
      <go_id>GO:0004857</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>glucuronosyltransferase activity</description>
      <go_id>GO:0015020</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>retinoic acid binding</description>
      <go_id>GO:0001972</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>steroid binding</description>
      <go_id>GO:0005496</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>bilirubin conjugation</description>
      <go_id>GO:0006789</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>biphenyl catabolic process</description>
      <go_id>GO:0070980</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to ethanol</description>
      <go_id>GO:0071361</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to glucocorticoid stimulus</description>
      <go_id>GO:0071385</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>digestion</description>
      <go_id>GO:0007586</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>drug metabolic process</description>
      <go_id>GO:0017144</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>estrogen metabolic process</description>
      <go_id>GO:0008210</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>flavone metabolic process</description>
      <go_id>GO:0051552</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>flavonoid glucuronidation</description>
      <go_id>GO:0052696</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>heme catabolic process</description>
      <go_id>GO:0042167</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>liver development</description>
      <go_id>GO:0001889</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of steroid metabolic process</description>
      <go_id>GO:0045939</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>organ regeneration</description>
      <go_id>GO:0031100</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to drug</description>
      <go_id>GO:0042493</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to lipopolysaccharide</description>
      <go_id>GO:0032496</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to nutrient</description>
      <go_id>GO:0007584</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to starvation</description>
      <go_id>GO:0042594</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>retinoic acid metabolic process</description>
      <go_id>GO:0042573</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>xenobiotic glucuronidation</description>
      <go_id>GO:0052697</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Microsome</subcellular_location>
    <subcellular_location>Endoplasmic reticulum membrane</subcellular_location>
    <subcellular_location>Single-pass membrane protein (Potential)</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>2</chromosome_location>
    <locus>2q37</locus>
    <gene_sequence>&gt;1602 bp
ATGGCTGTGGAGTCCCAGGGCGGACGCCCACTTGTCCTGGGCCTGCTGCTGTGTGTGCTG
GGCCCAGTGGTGTCCCATGCTGGGAAGATACTGTTGATCCCAGTGGATGGCAGCCACTGG
CTGAGCATGCTTGGGGCCATCCAGCAGCTGCAGCAGAGGGGACATGAAATAGTTGTCCTA
GCACCTGACGCCTCGTTGTACATCAGAGACGGAGCATTTTACACCTTGAAGACGTACCCT
GTGCCATTCCAAAGGGAGGATGTGAAAGAGTCTTTTGTTAGTCTCGGGCATAATGTTTTT
GAGAATGATTCTTTCCTGCAGCGTGTGATCAAAACATACAAGAAAATAAAAAAGGACTCT
GCTATGCTTTTGTCTGGCTGTTCCCACTTACTGCACAACAAGGAGCTCATGGCCTCCCTG
GCAGAAAGCAGCTTTGATGTCATGCTGACGGACCCTTTCCTTCCTTGCAGCCCCATCGTG
GCCCAGTACCTGTCTCTGCCCACTGTATTCTTCTTGCATGCACTGCCATGCAGCCTGGAA
TTTGAGGCTACCCAGTGCCCCAACCCATTCTCCTACGTGCCCAGGCCTCTCTCCTCTCAT
TCAGATCACATGACCTTCCTGCAGCGGGTGAAGAACATGCTCATTGCCTTTTCACAGAAC
TTTCTGTGCGACGTGGTTTATTCCCCGTATGCAACCCTTGCCTCAGAATTCCTTCAGAGA
GAGGTGACTGTCCAGGACCTATTGAGCTCTGCATCTGTCTGGCTGTTTAGAAGTGACTTT
GTGAAGGATTACCCTAGGCCCATCATGCCCAATATGGTTTTTGTTGGTGGAATCAACTGC
CTTCACCAAAATCCACTATCCCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACAT
GGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATG
GCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACC
CGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTG
CTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAA
AGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAAT
GCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCT
GAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATC
ATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTC
TGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGAC
CTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTG
ACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAA
AAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>533</residue_number>
    <molecular_weight>59590.91</molecular_weight>
    <theoretical_pi>8.006</theoretical_pi>
    <pfams>
      <pfam>
        <name>UDPGT</name>
        <pfam_id>PF00201</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;UDP-glucuronosyltransferase 1-1
MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVL
APDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDS
AMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLE
FEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQR
EVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEH
GIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDL
LGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTS
EDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHD
LTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH</protein_sequence>
  </protein_properties>
  <genbank_protein_id/>
  <uniprot_id>P22309</uniprot_id>
  <uniprot_name>UD11_HUMAN</uniprot_name>
  <pdb_ids>
  </pdb_ids>
  <genbank_gene_id>M57899</genbank_gene_id>
  <genecard_id>UGT1A1</genecard_id>
  <geneatlas_id>UGT1A1</geneatlas_id>
  <hgnc_id>HGNC:12530</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Ritter JK, Crawford JM, Owens IS: Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem. 1991 Jan 15;266(2):1043-7.</reference_text>
      <pubmed_id>1898728</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61.</reference_text>
      <pubmed_id>1339448</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68.</reference_text>
      <pubmed_id>11434514</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.</reference_text>
      <pubmed_id>15815621</pubmed_id>
    </reference>
    <reference>
      <reference_text>Meunier L, Usherwood YK, Chung KT, Hendershot LM: A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell. 2002 Dec;13(12):4456-69.</reference_text>
      <pubmed_id>12475965</pubmed_id>
    </reference>
    <reference>
      <reference_text>Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.</reference_text>
      <pubmed_id>19159218</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bosma PJ, Chowdhury JR, Huang TJ, Lahiri P, Elferink RP, Van Es HH, Lederstein M, Whitington PF, Jansen PL, Chowdhury NR: Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J. 1992 Jul;6(10):2859-63.</reference_text>
      <pubmed_id>1634050</pubmed_id>
    </reference>
    <reference>
      <reference_text>Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, Yazawa T, Sato H, Koiwai O: Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun. 1993 Dec 30;197(3):1239-44.</reference_text>
      <pubmed_id>8280139</pubmed_id>
    </reference>
    <reference>
      <reference_text>Moghrabi N, Clarke DJ, Boxer M, Burchell B: Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics. 1993 Oct;18(1):171-3.</reference_text>
      <pubmed_id>8276413</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ritter JK, Yeatman MT, Kaiser C, Gridelli B, Owens IS: A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem. 1993 Nov 5;268(31):23573-9.</reference_text>
      <pubmed_id>8226884</pubmed_id>
    </reference>
    <reference>
      <reference_text>Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, Trivin F, Chowdhury NR, Chowdhury JR, Munnich A, Odievre M: Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet. 1994 Dec;94(6):693-7.</reference_text>
      <pubmed_id>7989045</pubmed_id>
    </reference>
    <reference>
      <reference_text>Erps LT, Ritter JK, Hersh JH, Blossom D, Martin NC, Owens IS: Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest. 1994 Feb;93(2):564-70.</reference_text>
      <pubmed_id>7906695</pubmed_id>
    </reference>
    <reference>
      <reference_text>Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, Jansen PL, Oude Elferink RP: Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest. 1994 Dec;94(6):2385-91.</reference_text>
      <pubmed_id>7989595</pubmed_id>
    </reference>
    <reference>
      <reference_text>Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H: Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet. 1995 Apr 15;345(8955):958-9.</reference_text>
      <pubmed_id>7715297</pubmed_id>
    </reference>
    <reference>
      <reference_text>Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP: A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 1996 Jul 29;390(3):294-8.</reference_text>
      <pubmed_id>8706880</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ciotti M, Chen F, Rubaltelli FF, Owens IS: Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim Biophys Acta. 1998 Jul 1;1407(1):40-50.</reference_text>
      <pubmed_id>9639672</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yamamoto K, Soeda Y, Kamisako T, Hosaka H, Fukano M, Sato H, Fujiyama Y, Adachi Y, Satoh Y, Bamba T: Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II. J Hum Genet. 1998;43(2):111-4.</reference_text>
      <pubmed_id>9621515</pubmed_id>
    </reference>
    <reference>
      <reference_text>Maruo Y, Sato H, Yamano T, Doida Y, Shimada M: Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr. 1998 Jun;132(6):1045-7.</reference_text>
      <pubmed_id>9627603</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR: Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000 Oct;16(4):297-306.</reference_text>
      <pubmed_id>11013440</pubmed_id>
    </reference>
    <reference>
      <reference_text>Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M: Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000 Nov;106(5):E59.</reference_text>
      <pubmed_id>11061796</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kadakol A, Sappal BS, Ghosh SS, Lowenheim M, Chowdhury A, Chowdhury S, Santra A, Arias IM, Chowdhury JR, Chowdhury NR: Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet. 2001 Apr;38(4):244-9.</reference_text>
      <pubmed_id>11370628</pubmed_id>
    </reference>
    <reference>
      <reference_text>Labrune P, Myara A, Chalas J, Le Bihan B, Capel L, Francoual J: Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome. Hum Mutat. 2002 Nov;20(5):399-401.</reference_text>
      <pubmed_id>12402338</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sutomo R, Laosombat V, Sadewa AH, Yokoyama N, Nakamura H, Matsuo M, Nishio H: Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int. 2002 Aug;44(4):427-32.</reference_text>
      <pubmed_id>12139570</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ohnishi A, Emi Y: Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II. Biochem Biophys Res Commun. 2003 Oct 24;310(3):735-41.</reference_text>
      <pubmed_id>14550264</pubmed_id>
    </reference>
    <reference>
      <reference_text>Servedio V, d'Apolito M, Maiorano N, Minuti B, Torricelli F, Ronchi F, Zancan L, Perrotta S, Vajro P, Boschetto L, Iolascon A: Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum Mutat. 2005 Mar;25(3):325.</reference_text>
      <pubmed_id>15712364</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Bilirubin diglucuronide</name>
        <accession>HMDB03325</accession>
      </metabolite>
      <reference>
        <reference_text>Meunier CJ, Verbeeck RK: Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats. Drug Metab Dispos. 1999 Jan;27(1):26-31.</reference_text>
        <pubmed_id>9884306</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Acetaminophen glucuronide</name>
        <accession>HMDB10316</accession>
      </metabolite>
      <reference>
        <reference_text>Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, Mackenzie PI: Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther. 2001 Dec;299(3):998-1006.</reference_text>
        <pubmed_id>11714888</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ethyl glucuronide</name>
        <accession>HMDB10325</accession>
      </metabolite>
      <reference>
        <reference_text>Foti RS, Fisher MB: Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int. 2005 Oct 29;153(2-3):109-16. Epub 2005 Jan 15.</reference_text>
        <pubmed_id>16139098</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Bilirubin glucuronide</name>
        <accession>HMDB10332</accession>
      </metabolite>
      <reference>
        <reference_text>Meunier CJ, Verbeeck RK: Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats. Drug Metab Dispos. 1999 Jan;27(1):26-31.</reference_text>
        <pubmed_id>9884306</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ketoprofen glucuronide</name>
        <accession>HMDB10334</accession>
      </metabolite>
      <reference>
        <reference_text>Kuehl GE, Lampe JW, Potter JD, Bigler J: Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos. 2005 Jul;33(7):1027-35. Epub 2005 Apr 20.</reference_text>
        <pubmed_id>15843492</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Retinyl beta-glucuronide</name>
        <accession>HMDB10340</accession>
      </metabolite>
      <reference>
        <reference_text>Genchi G, Wang W, Barua A, Bidlack WR, Olson JA: Formation of beta-glucuronides and of beta-galacturonides of various retinoids catalyzed by induced and noninduced microsomal UDP-glucuronosyltransferases of rat liver. Biochim Biophys Acta. 1996 Mar 15;1289(2):284-90.</reference_text>
        <pubmed_id>8600986</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid</name>
        <accession>HMDB10343</accession>
      </metabolite>
      <reference>
        <reference_text>Kuehl GE, Lampe JW, Potter JD, Bigler J: Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos. 2005 Jul;33(7):1027-35. Epub 2005 Apr 20.</reference_text>
        <pubmed_id>15843492</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Estradiol</name>
        <accession>HMDB00151</accession>
      </metabolite>
      <reference>
        <reference_text>Hanioka N, Tanabe N, Jinno H, Tanaka-Kagawa T, Nagaoka K, Naito S, Koeda A, Narimatsu S: Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes. Life Sci. 2010 Aug 14;87(7-8):261-8. Epub 2010 Jul 8.</reference_text>
        <pubmed_id>20620155</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Estradiol</name>
        <accession>HMDB00151</accession>
      </metabolite>
      <reference>
        <reference_text>Guillemette C, Belanger A, Lepine J: Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res. 2004;6(6):246-54. Epub 2004 Sep 27.</reference_text>
        <pubmed_id>15535854</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Morphine</name>
        <accession>HMDB14440</accession>
      </metabolite>
      <reference>
        <reference_text>Ohno S, Kawana K, Nakajin S: Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties. Drug Metab Dispos. 2008 Apr;36(4):688-94. Epub 2008 Jan 10.</reference_text>
        <pubmed_id>18187562</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4'-Hydroxydiclofenac</name>
        <accession>HMDB13974</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>E-3179</name>
        <accession>HMDB13846</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mycophenolate mofetil</name>
        <accession>HMDB14826</accession>
      </metabolite>
      <reference>
        <reference_text>Miles KK, Kessler FK, Smith PC, Ritter JK: Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid. Drug Metab Dispos. 2006 Sep;34(9):1632-9. Epub 2006 Jun 21.</reference_text>
        <pubmed_id>16790558</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Naltrexone</name>
        <accession>HMDB14842</accession>
      </metabolite>
      <reference>
        <reference_text>Antonilli L, Brusadin V, Milella MS, Sobrero F, Badiani A, Nencini P: In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat. Biochem Pharmacol. 2008 Sep 1;76(5):672-9. Epub 2008 Jul 1.</reference_text>
        <pubmed_id>18639530</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Flurbiprofen</name>
        <accession>HMDB14850</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Irinotecan</name>
        <accession>HMDB14900</accession>
      </metabolite>
      <reference>
        <reference_text>Kuhn JG: Pharmacology of irinotecan.  Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):39-42.</reference_text>
        <pubmed_id>9726089</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>O-Desmethylnaproxen</name>
        <accession>HMDB13989</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4-Hydroxypropofol</name>
        <accession>HMDB14018</accession>
      </metabolite>
      <reference>
        <reference_text>Mano Y, Usui T, Kamimura H: Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes. Basic Clin Pharmacol Toxicol. 2007 Sep;101(3):211-4.</reference_text>
        <pubmed_id>17697043</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Suprofen</name>
        <accession>HMDB15008</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ezetimibe</name>
        <accession>HMDB15108</accession>
      </metabolite>
      <reference>
        <reference_text>Oswald S, Nassif A, Modess C, Keiser M, Ulrich A, Runge D, Hanke U, Lutjohann D, Engel A, Weitschies W, Siegmund W: Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers. Clin Pharmacol Ther. 2011 Apr;89(4):524-8. Epub 2011 Mar 2.</reference_text>
        <pubmed_id>21368751</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ezetimibe</name>
        <accession>HMDB15108</accession>
      </metabolite>
      <reference>
        <reference_text>Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB: Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet. 2005;44(5):467-94.</reference_text>
        <pubmed_id>15871634</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mycophenolic acid</name>
        <accession>HMDB15159</accession>
      </metabolite>
      <reference>
        <reference_text>Dostalek M, Court MH, Hazarika S, Akhlaghi F: Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite. Drug Metab Dispos. 2011 Mar;39(3):448-55. Epub 2010 Dec 1.</reference_text>
        <pubmed_id>21123165</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mycophenolic acid</name>
        <accession>HMDB15159</accession>
      </metabolite>
      <reference>
        <reference_text>Miles KK, Kessler FK, Smith PC, Ritter JK: Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid. Drug Metab Dispos. 2006 Sep;34(9):1632-9. Epub 2006 Jun 21.</reference_text>
        <pubmed_id>16790558</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Ellis E, Wagner M, Lammert F, Nemeth A, Gumhold J, Strassburg CP, Kylander C, Katsika D, Trauner M, Einarsson C, Marschall HU: Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin. J Hepatol. 2006 Jan;44(1):243-5. Epub 2005 Oct 27.</reference_text>
        <pubmed_id>16288819</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Jemnitz K, Lengyel G, Vereczkey L: In vitro induction of bilirubin conjugation in primary rat hepatocyte culture.  Biochem Biophys Res Commun. 2002 Feb 15;291(1):29-33.</reference_text>
        <pubmed_id>11829457</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Abacavir</name>
        <accession>HMDB15182</accession>
      </metabolite>
      <reference>
        <reference_text>Yuen GJ, Weller S, Pakes GE: A review of the pharmacokinetics of abacavir.  Clin Pharmacokinet. 2008;47(6):351-71.</reference_text>
        <pubmed_id>18479171</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Nilotinib</name>
        <accession>HMDB15595</accession>
      </metabolite>
      <reference>
        <reference_text>Haouala A, Widmer N, Duchosal MA, Montemurro M, Buclin T, Decosterd LA: Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood. 2011 Feb 24;117(8):e75-87. Epub 2010 Sep 1.</reference_text>
        <pubmed_id>20810928</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
